Every patient deserves the best therapy.

Cannovum is a fully licensed pharmaceutical wholesaler, importer and manufacturer of high-quality medical cannabis.

About Cannovum
New

Pharmacy Workshops

Secure a free, customized workshop now, online or in your pharmacy.

Learn more
Customer and product service
Services

Your advantages

Free Shipping

No postage costs for you. Our delivery is free of charge, with no minimum order value.

Free return

You can return all unopened products easily and free of charge. We will refund the full amount.

Discount

We grant a 3% discount on all orders with a payment term of 14 days.
General payment term: 30 days.

Values

Patients first

The well-being of patients is our highest priority. We aim to facilitate the development of a regulated cannabis market in Europe to help patients obtain the best possible therapy.

Values

Safety and Quality

Safety and quality are the most important factors for us. Our cannabis is imported from GMP-certified producers, who adhere to the highest standards. Every step of our supply chain from the cultivation to the distribution is regulated and controlled.

Values

Cannabis for Europe

Although the beneficial medical properties of cannabis are increasingly established, developments aimed at leveraging these benefits have been slow in Europe. Cannovum clearly focuses on the European market, pioneering our cannabis revolution.

For pharmacies

Our Onlineshop

Pharmacists can easily register with our online shop to place orders. If you have any questions about our products and the associated service, please contact our trained service staff.

Sign up
Screenshot of Cannovum's Online Shop
Network

Our partners

Partner BPCPartner Hanfverband
News

Latest News

News
May 6, 2021

Cannovum AG’s direct listing on the Düsseldorf Stock Exchange

First German medical cannabis company listed on the German stock exchange: shares in Cannovum AG can now be traded on the OTC market of the Düsseldorf Stock Exchange.

News
February 12, 2021

Cannovum is now part of the BPC

We are excited to announce our partnership with the BPC, who promote sustainable development of cannabinoid therapies and strengthen the legitimacy of the pharmaceutical cannabinoid industry.

News
January 5, 2021

Handelsblatt

Handelsblatt published an entrepreneur profile that covers the motivation of our CEO Pia Marten behind founding Cannovum AG. Find the article here:

For investors

If you would like to invest in Cannovum feel free to check and contact us in our investor relations page.

Investor relations

Cannovum Newsletter

Get the latest information and insights:

check_circle
Successfully subscribed
Something went wrong while submitting the form.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.